G&E Herbal Biotechnology

G&E Herbal Biotechnology is a leading biotech company focuses on the developing and commercializing novel botanical products. Under the visionary leadership of CEO Prof./Dr. Kou-Wha Kuo, G&E Herbal Biotechnology has pushed the boundaries of science, pioneering advancements in botanical new drugs. As a publicly traded company (TWSE: 4911) since its founding in 2002, G&E Herbal Biotech has remained steadfast in its commitment to research and development. Leveraging proprietary and innovative technologies, the company produces high-quality plant-based pharmaceuticals, health supplements, and skincare products. Notably, G&E Herbal Biotech is among Taiwan’s select few PIC/S GMP-certified manufacturers specializing in plant-based pharmaceutical products. The company operates state-of-the-art facilities for plant extraction, purification, and GMP-certified cosmetics production, with two operating sites located in the Southern Taiwan Science Park and Tainan Technology Industrial Park. The company has achieved significant milestones, including the prestigious "National Invention Gold Medal" awarded by the Intellectual Property Office under the Ministry of Economic Affairs, Taiwan in 2011. With independently developed technologies, G&E Herbal Biotech has revolutionized plant-based medicine, pioneering advancements in the field. The company’s core project, SR-T100, has demonstrated promising results in clinical trials, with the injection form reaching Phase I and the gel formulation advancing to Phase III. Moreover, the approved herbal medicine, Hepanamin®, targets liver-related diseases, have marketed in collaboration with trusted partners. Expanding beyond pharmaceuticals, G&E Herbal Biotech also offers a range of health supplements and cosmetics, all featuring patented technologies that highlight its commitment to quality and innovation.